News Results
There are 983,012 News Results
May 29, 2025
- Company to Present Eight Posters and Two Oral Presentations, Including New Analyses From ALKS 2680 Phase 1 Study -
Sep 10, 2025
WALTHAM, Mass., Sept. 10, 2025 /PRNewswire/ -- Artificial Intelligence (AI) is reshaping industries, demanding meticulous implementation strategies. At AMC Bridge, we understand that harnessing AI's power is no longer a...
May 29, 2017
ANDOVER, Mass., May 30, 2017 /PRNewswire/ -- Casa Systems, a worldwide leader in next-generation distributed and virtualized architectures in mobile, fixed broadband and cable access networks, today announced the launch...
Jun 2, 2017
REDWOOD CITY, Calif., June 3, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) in...
Jun 13, 2017
NEW YORK, June 14, 2017 /PRNewswire/ -- New York Cruise Lines , parent company of iconic Circle Line Sightseeing Cruises, is adding a new fleet to their exemplary roster with...
Jun 21, 2017
MUNICH, June 22, 2017 /PRNewswire/ -- IBM (NYSE: IBM ) today announced sweeping advances to its data governance and data science initiatives designed to help developers and analysts tap into...
Aug 22, 2017
OSLO, Norway, August 23, 2017 /PRNewswire/ -- Nordic Nanovector (OSE: NANO) publiserer i dag resultater for andre kvartal og første halvar 2017. Selskapets ledelse vil gi en presentasjon av resultatene...
Aug 22, 2017
NEW YORK, Aug. 23, 2017 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area. You can also submit a...
Sep 11, 2017
SAN FRANCISCO, Sept. 12, 2017 /PRNewswire/ -- Salesforce.org, the philanthropic arm of Salesforce (NYSE: CRM), announced today it will donate $12.2 million to San Francisco Unified School District (SFUSD) and...
Oct 8, 2017
BASEL, Switzerland, October 10, 2017 /PRNewswire/ -- Mundipharma EDO GmbH (EDO) has begun a US Phase 1/2 clinical study for tinostamustine (EDO-S101) in patients with advanced solid tumors at Stanford...
